An arthritis drug -- #Tofacitinib -- developed by US biopharmaceutical #Pfizer (@pfizer) has shown to be effective in reducing the risk of death or respiratory failure in hospitalised adult patients with #COVID19 pneumonia who were not on ventilation, according to a study. pic.twitter.com/AUUHFvdSAj— IANS Tweets (@ians_india) June 17, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


